American Oncology Network, Inc. (AONC)
USD 4.49
(2.28%)
USD 4.49
(2.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -18.11 Million | -6.78 Million | -26.33 Million | 37.24 Million |
| Net Income | -63.15 Million | 2.58 Million | -105 Thousand | 21.95 Million |
| Depreciation & Amortization | 16.73 Million | 17.08 Million | 6.07 Million | 3.65 Million |
| Deferred income taxes | 384 Thousand | 574.99 Thousand | 786 Thousand | -1.17 Million |
| Stock-based compensation | 4.87 Million | - | 20 Thousand | 20 Thousand |
| Change in working capital | 12.07 Million | -26.96 Million | -34.77 Million | 12.12 Million |
| Other non-cash items | 10.96 Million | 627 Thousand | 1.65 Million | 670 Thousand |
| Investing Cash Flow | -35.53 Million | -13.99 Million | -10.69 Million | -14.67 Million |
| Investments in PPE | -12.28 Million | -7.19 Million | -8.32 Million | -12.22 Million |
| Acquisitions | 704 Thousand | -5000.00 | -3.21 Million | -933 Thousand |
| Investment purchases | -67.39 Million | -12.61 Million | -333.5 Million | - |
| Sales/Maturities of investments | 42.32 Million | 2.65 Million | - | - |
| Other Investing Activities | 1.12 Million | 3.17 Million | 843 Thousand | -1.52 Million |
| Financing Cash Flow | 55.26 Million | 15.34 Million | 26.54 Million | 16.25 Million |
| Debt repayment | -593 Thousand | -426 Thousand | -37.3 Million | -24.58 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | -9.56 Million | - | - | - |
| Common Stock Issuance | 64.99 Million | -206 Thousand | 25 Million | 28.5 Million |
| Other Financing Activities | 431 Thousand | 15.77 Million | 38.84 Million | 12.34 Million |
| Accounts receivables | 6.94 Million | -24.87 Million | -30.8 Million | -35.48 Million |
| Accounts payables | 20.06 Million | 14.07 Million | 21.67 Million | 34 Million |
| Inventory | -8.09 Million | -1.94 Million | -10.26 Million | -6.27 Million |
| Other working capital | -6.85 Million | -14.21 Million | -15.39 Million | 19.88 Million |
| Cash at beginning of period | 26.92 Million | 32.35 Million | 42.84 Million | 4.01 Million |
| Cash at end of period | 28.53 Million | 26.92 Million | 32.35 Million | 42.84 Million |
| Capital Expenditure | -12.28 Million | -7.19 Million | -8.32 Million | -12.22 Million |
| Effect of forex changes on cash | - | -797.5 Million | 813.79 Million | - |
| Net cash flow / Change in cash | 1.61 Million | -5.42 Million | -10.48 Million | 38.82 Million |
| Free Cash Flow | -30.4 Million | -13.97 Million | -34.66 Million | 25.02 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -24.96 Million | -22.35 Million | -63.15 Million | -1.79 Million | -1.71 Million | -1.48 Million |
| Depreciation & Amortization | 4.54 Million | 4.17 Million | 16.73 Million | 3.94 Million | 4.18 Million | 4.43 Million |
| Deferred income taxes | 2.89 Million | 309 Thousand | 384 Thousand | 75 Thousand | - | -574.99 Thousand |
| Stock-based compensation | 10.09 Million | -1000.00 | 4.87 Million | 4.87 Million | - | - |
| Change in working capital | 53.61 Million | 5.1 Million | 12.07 Million | 5.23 Million | 1.27 Million | -3.55 Million |
| Other non-cash items | 215 Thousand | 808 Thousand | 10.96 Million | -8.41 Million | 179.91 Thousand | 176 Thousand |
| Investing Cash Flow | 1.52 Million | -10.86 Million | -35.53 Million | -346.07 Million | -50 Thousand | -2.64 Million |
| Investments in PPE | -4.13 Million | -2.75 Million | -12.28 Million | -9.52 Million | -4.12 Million | -2.77 Million |
| Acquisitions | - | 699 Thousand | 704 Thousand | 139 Thousand | - | - |
| Investment purchases | -7.06 Million | -46.57 Million | -67.39 Million | -20.62 Million | -50 Thousand | -1.44 Million |
| Sales/Maturities of investments | 12.62 Million | 37.38 Million | 42.32 Million | -316.8 Million | 812 Thousand | 1.42 Million |
| Other Investing Activities | 99 Thousand | 380 Thousand | 1.12 Million | 740 Thousand | 477 Thousand | 153 Thousand |
| Financing Cash Flow | -254 Thousand | -295 Thousand | 55.26 Million | 376.07 Million | 307 Thousand | -105 Thousand |
| Debt repayment | -157 Thousand | -206 Thousand | -593 Thousand | -587 Thousand | -50 Thousand | -105 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -97 Thousand | -88 Thousand | -9.56 Million | 321.16 Million | -8.17 Million | -321.16 Million |
| Common Stock Issuance | -97 Thousand | - | 64.99 Million | 64.24 Million | - | - |
| Other Financing Activities | - | -1000.00 | 431 Thousand | -8.29 Million | 257 Thousand | -320.96 Million |
| Accounts receivables | -3.14 Million | 11.88 Million | 6.94 Million | 4.12 Million | 7.65 Million | -16.71 Million |
| Accounts payables | 61.67 Million | 6.17 Million | 20.06 Million | -1.78 Million | 10.35 Million | 5.31 Million |
| Inventory | 281 Thousand | -6.72 Million | -8.09 Million | 4.04 Million | -10.26 Million | 4.85 Million |
| Other working capital | -4.66 Million | -6.24 Million | -6.85 Million | 6.67 Million | 1.27 Million | -1.72 Million |
| Cash at beginning of period | 28.53 Million | 51.65 Million | 26.92 Million | 2044.00 | 3975.00 | 26.92 Million |
| Cash at end of period | 74.94 Million | 28.53 Million | 28.53 Million | 51.65 Million | 2044.00 | 23.84 Million |
| Capital Expenditure | -4.13 Million | -2.75 Million | -12.28 Million | -9.52 Million | -4.12 Million | -2.77 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 46.4 Million | -23.11 Million | 1.61 Million | 51.65 Million | -1931.00 | -3.07 Million |
| Free Cash Flow | 41 Million | -14.71 Million | -30.4 Million | -14.42 Million | -4.38 Million | -3.1 Million |
000850
002515
ABT
002187
603344
DRRX